Trial Details

COMPLETED
Basic Information
Clinical ID c1508
Identifier NCT02646657
Trial Title An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Colitis, Ulcerative
Interventions DRUG: Vedolizumab 300 mg
Participant Information
Sponsor Geert D'Haens
City Bonheiden
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2025-07-15
Primary Completion Date 2025-08-20
Completion Date 2025-08-20